Tourmaline Bio
TRML
TRML
101 hedge funds and large institutions have $464M invested in Tourmaline Bio in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 13 closing their positions.
Holders
101
Holders Change
+9
Holders Change %
+9.78%
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
22
Increased
40
Reduced
22
Closed
13
Calls
$89K
Puts
$251K
Net Calls
-$162K
Net Calls Change
-$188K
Top Buyers
1 |
P
1
Pfizer
New York
|
$25.8M |
2 |
![]()
2
Adage Capital Partners
Boston,
Massachusetts
|
$12.2M |
3 |
3
State Street
Boston,
Massachusetts
|
$16.2M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$13.1M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$3.84M |